Susanti Susanti

Susanti Susanti

Auto-generated profile, based on publicly available information

Susanti Susanti

Pathgen Diagnostik Teknologi, Ir. Soekarno Science and Technology Park, National Research and Innovation Agency Republic of Indonesia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2018 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
SSSusanti Susanti
Susanti Susanti
WFWakkas Fadhil
Wakkas Fadhil
HEHenry Okuchukwu Ebili
Henry Okuchukwu Ebili
AAAbutaleb Asiri
Abutaleb Asiri
ANAusrine Nestarenkaite
Ausrine Nestarenkaite
MIMohammad Ilyas
Mohammad Ilyas
Aims: We sought to use PCR followed by high-resolution melting analysis to develop a single closed-tube screening panel to screen for Lynch syndrome. This comprises tests for microsatellite instability (MSI), MLH1 methylation promoter and BRAF mutation. Methods: For MSI testing, five mononucleotide markers (BAT25, BAT26, BCAT25, MYB, EWSR1) were developed. In addition, primers were designed to interrogate Region C of the MLH1 promoter for methylation (using bisulphite-modified DNA) and to test for mutations in codon 600 of BRAF. Two separate cohorts from Nottingham (n=99, 46 with MSI, 53 being microsatellite stable (MSS)) and Edinburgh (n=88, 45 MSI, 43 MSS) were tested. Results: All the cases (n=187) were blind tested for MSI and all were correctly characterised by our panel. The MLH1 promoter and BRAF were tested only in the Nottingham cohort. Successful blinded analysis was performed on the MLH1 promoter in 97 cases. All MSS cases showed a pattern of non-methylation while 41/44 cases with MSI showed full methylation. The three cases with MSI and a non-methylated pattern had aberrations in MSH2 and MSH6 expression. BRAF mutation was detected in 61% of MSI cases and 11% of MSS cases. Finally, 12 cases were blind screened by using the whole panel as a single test. Of these, five were identified as MSS, four as MSI/non-LS and three as MSI/possible LS. These results were concordant with the previous data. Conclusion: We describe the Nottingham Lynch Syndrome Test (N_LyST). This is a quick, simple and cheap method for screening for Lynch syndrome.

25 October 2018 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
SSSusanti Susanti
Susanti Susanti
WFWakkas Fadhil
Wakkas Fadhil
SMShamayal Murtaza
Shamayal Murtaza
JHJames C Hassall
James C Hassall
HEHenry O Ebili
Henry O Ebili
MIMohammad Ilyas
Mohammad Ilyas
Mutation in KRAS, BRAF and PIK3CA are commonly present in colorectal cancer (CRC). KRAS and BRAF form part of the mitogen-activated protein kinase (MAPK) signalling pathway and KRAS lies immediately upstream of BRAF. Consequently, KRAS and BRAF mutations are mutually exclusive with mutation in either one causing activation of MAPK signalling.1 PIK3CA forms part of the phosphatidylinositide‐3‐kinase PI3K signalling pathway, and several studies have shown a significant association of KRAS and PIK3CA mutation in several cancer types including CRC.1–3 At face value, there would appear to be positive co-selection of MAPK and PI3K signalling activation implying synergy between these two pathways. If this were true, then a similar positive association would be expected between mutation of BRAF and PIK3CA. To date, less consistent or no association of BRAF and PIK3CA mutation has been reported.1 3 4 However, it is well established that BRAF mutation is strongly associated with microsatellite instability (MSI) in CRC. We therefore sought to test the association between mutation of BRAF and PIK3CA …

1 August 2024 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
DHDidik Setyo Heriyanto
Didik Setyo Heriyanto
NYNaomi Yoshuantari
Naomi Yoshuantari
GAGilang Akbariani
Gilang Akbariani
Vincent LauVincent Lau
Vincent Lau
HHHanifa Hanini
Hanifa Hanini
SSSusanti Susanti
Susanti Susanti
High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations

6 June 2025 in Research Square
Verified
Preprint
Open access
PDF file
YHYourae Hong
Yourae Hong
SSSusanti Susanti
Susanti Susanti
MMMegan L. Mills
Megan L. Mills
KGKathryn L. Gilroy
Kathryn L. Gilroy
ZHZedong Hu
Zedong Hu
STSabine Tejpar
Sabine Tejpar
In the colonic epithelium, fetal programming is induced by Yes-associated protein (YAP) signaling, which is associated with tumorigenesis and progression in colorectal cancer (CRC). While CRC was long considered a WNT driven disease, here we show that fetal programmed cells with activated YAP signaling can arise independently of WNT activation. Fetal programmed cells, in the presence of hyper- or hypo-activated WNT, have different characteristics and are associated with poor relapse. Furthermore, using various mouse models, we demonstrated the conserved characteristics of two different fetal programmed cell states with different WNT activation, which can be switched from a hyperactivated to hypoactivated WNT state based on genetic alteration, particularly Kras mutation. Taken together, these data redefine the key determinants of epithelial cell states in colorectal cancer and integrate emerging preclinical biology into a robust landscape of states observed in human and mouse.

3 November 2024 in Epigenetics
Verified
Journal Article
Open access
AEAlim El-Hakim
Alim El-Hakim
ICInswasti Cahyani
Inswasti Cahyani
MAMuhammad Zulfikar Arief
Muhammad Zulfikar Arief
GAGilang Akbariani
Gilang Akbariani
ARAsep Muhamad Ridwanuloh
Asep Muhamad Ridwanuloh
AUAhmad Rusdan Handoyo Utomo
Ahmad Rusdan Handoyo Utomo
Stunting is the result of chronic malnutrition due to the lack of micronutrient-based methyl donors required for epigenetic programming during the first 1000 days of life. Methylation studies using bisulfite conversion from blood DNA are invasive and may not be practical for large-scale epidemiological investigation or nutrition intervention programs. Buccal epithelial methylation may reflect early germline methylation. Therefore, buccal cells can serve as convenient sample sources to collect biomarkers associated with the risk of stunting. This study aims to describe the feasibility of nanopore adaptive sampling in detecting DNA methylation from children’s buccal DNA. We used adaptive sampling of Oxford Nanopore Technology on barcoded samples to describe differential methylation associated with malnutrition. Overall, the level of 5-methylcytosine (5mC) was lower in stunted children than in normal children. We also found differentially methylated regions at the MIR6724 and RNA45SN1 gene loci on chromosome 21, which was higher in stunted children than in normal children. We described and detected differential DNA methylation in the locus previously not known to be associated with stunting. Interestingly, this locus on chromosome 21 has been implicated in the stunted phenotype of Down syndrome.

4 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DHDidik Setyo Heriyanto
Didik Setyo Heriyanto
NYNaomi Yoshuantari
Naomi Yoshuantari
GAGilang Akbariani
Gilang Akbariani
Vincent LauVincent Lau
Vincent Lau
HHHanifa Hanini
Hanifa Hanini
SSSusanti Susanti
Susanti Susanti
Background In Indonesia, early-onset colorectal cancer (EOCRC) rates are higher in patients <50 years old compared to western populations, possibly due to a higher frequency of Lynch Syndrome (LS) in CRC patients. We aim to examine the association of KRAS and PIK3CA mutation with LS. Methods In this cross-sectional study, the PCR-HRM-based test was used for screening of MSI mononucleotide markers (BAT25, BAT26, BCAT25, MYB, EWSR1), MLH1 promoter methylation, and oncogene mutations of BRAF(V600E), KRAS (exon 2 and 3), and PIK3CA (exon 9 and 20) in FFPE DNA samples. Results All the samples (n=244) were from Dr. Sardjito General Hospital Yogyakarta, Indonesia. KRAS and PIK3CA mutations were found in 151/244 (61.88%) and 107/244 (43.85%) of samples respectively. KRAS and PIK3CA mutations were significantly associated with MSI status in 32/42 (76.19%) and 25/42 (59.52%) of samples respectively. KRAS mutation was significantly associated with LS status in 26/32 (81.25%) of samples. The PIK3CA mutation was present in a higher proportion in LS samples of 19/32 (59.38%), but not statistically significant. Clinicopathology showed that KRAS mutation was significantly associated with right-sided CRC and higher histology grade in 39/151 (25.83%) and 24/151 (16.44%) samples respectively. PIK3CA mutation was significantly associated with female sex and lower levels of TILs in 62/107 (57.94%) and 26/107 (30.23%) samples respectively. KRAS and PIK3CA mutations did not significantly affect overall survival (120 months) in LS and non-LS patients. Conclusions High probability of LS in Indonesian CRC patients is associated with KRAS and PIK3CA mutations.